Loading...
XPAR
EQS
Market cap858mUSD
Jun 06, Last price  
50.10EUR
1D
-1.57%
1Q
31.50%
Jan 2017
43.35%
IPO
1,110.14%
Name

Equasens SA

Chart & Performance

D1W1MN
P/E
16.01
P/S
3.43
EPS
3.13
Div Yield, %
2.50%
Shrs. gr., 5y
Rev. gr., 5y
8.16%
Revenues
220m
+2.67%
60,669,00063,616,00067,357,00070,949,00074,800,00081,621,00091,551,00097,064,000108,722,000113,407,000114,560,000113,477,000128,381,000129,669,000148,480,000158,569,000171,754,000193,069,000214,075,000219,788,000
Net income
47m
+1.45%
5,011,0005,677,0007,304,000-8,554,0009,104,0009,609,00011,040,00011,754,00013,516,00015,825,00017,011,00018,792,00020,567,00023,135,00025,432,00028,403,00030,714,00039,119,00046,376,00047,047,000
CFO
62m
+8.10%
8,190,00010,541,0005,464,0008,836,00012,345,00014,010,00018,053,00012,290,00016,687,99919,961,00022,601,00027,186,00028,741,00040,665,00047,208,00047,516,00056,977,00061,590,000
Dividend
Jul 02, 20241.25 EUR/sh
Earnings
Jun 27, 2025

Profile

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
IPO date
Oct 20, 2000
Employees
1,221
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
219,788
2.67%
214,075
10.88%
Cost of revenue
149,910
75,104
Unusual Expense (Income)
NOPBT
69,878
138,971
NOPBT Margin
31.79%
64.92%
Operating Taxes
9,702
6,179
Tax Rate
13.88%
4.45%
NOPAT
60,176
132,792
Net income
47,047
1.45%
46,376
18.55%
Dividends
(17,289)
(15,757)
Dividend yield
1.86%
1.39%
Proceeds from repurchase of equity
14
6,064
BB yield
0.00%
-0.53%
Debt
Debt current
22,345
18,083
Long-term debt
57,676
58,424
Deferred revenue
(48,433)
Other long-term liabilities
9,803
54,356
Net debt
(68,977)
(8,764)
Cash flow
Cash from operating activities
61,590
56,977
CAPEX
(18,417)
(10,226)
Cash from investing activities
(50,532)
(18,342)
Cash from financing activities
(16,087)
(38,272)
FCF
1,102
131,420
Balance
Cash
54,685
68,012
Long term investments
94,313
17,259
Excess cash
138,009
74,567
Stockholders' equity
237,652
57,188
Invested Capital
168,693
210,596
ROIC
31.73%
64.52%
ROCE
22.67%
51.60%
EV
Common stock shares outstanding
15,174
15,174
Price
61.10
-18.21%
74.70
-20.53%
Market cap
927,139
-18.21%
1,133,507
-20.53%
EV
866,511
1,131,764
EBITDA
83,100
152,924
EV/EBITDA
10.43
7.40
Interest
669
679
Interest/NOPBT
0.96%
0.49%